Tiagabine treatment in kainic acid induced cerebellar lesion of dystonia rat model

Authors

  • Tsui-chin Wang Research Center for Neuroscience, Institute of Molecular Biosciences, Mahidol University, Salaya campus, Nakhon Pathom 73170, Thailand
  • Sukonthar Ngampramuan Research Center for Neuroscience, Institute of Molecular Biosciences, Mahidol University, Salaya campus, Nakhon Pathom 73170, Thailand
  • Naiphinich Kotchabhakdi Research Center for Neuroscience, Institute of Molecular Biosciences, Mahidol University, Salaya campus, Nakhon Pathom 73170, Thailand

DOI:

https://doi.org/10.17179/excli2016-482

Keywords:

dystonia, cerebellum, kainic acid, tiagabine, telemetry recording

Abstract

Dystonia is a neurological disorder characterized by excessive involuntary muscle contractions that lead to twisting movements. The exaggerated movements have been studied and have implicated basal ganglia as the point of origin. In more recent studies, the cerebellum has also been identified as the possible target of dystonia, in the search for alternative treatments. Tiagabine is a selective GABA transporter inhibitor, which blocks the reuptake and recycling of GABA. The study of GABAergic drugs as an alternative treatment for cerebellar induced dystonia has not been reported. In our study, tiagabine was i.p. injected into kainic acid induced, cerebellar dystonic adult rats, and the effects were compared with non-tiagabine injected and sham-operated groups. Beam walking apparatus, telemetric electromyography (EMG) recording, and histological verification were performed to confirm dystonic symptoms in the rats on post-surgery treatment. Involuntary dystonic spasm was observed with repetitive rigidity, and twisting movements in the rats were also confirmed by a high score on the dystonic scoring and a high amplitude on the EMG data. The rats with tiagabine treatment were scored based on motor amelioration assessed via beam walking. The result of this study suggests and confirms that low dose of kainic acid microinjection is sufficient to induce dystonia from the cerebellar vermis. In addition, from the results of the EMG recording and the behavioral assessment through beam walking, tiagabine is demonstrated as being effective in reducing dystonic spasm and may be a possible alternative therapeutic drug in the treatment of dystonia.

Downloads

Published

2016-11-17

How to Cite

Wang, T.- chin, Ngampramuan, S., & Kotchabhakdi, N. (2016). Tiagabine treatment in kainic acid induced cerebellar lesion of dystonia rat model. EXCLI Journal, 15, 716–729. https://doi.org/10.17179/excli2016-482

Issue

Vol. 15 (2016)

Section

Original articles

License

Authors who publish in this journal agree to the following terms:

  • The authors keep the copyright and grant the journal the right of first publication under the terms of the Creative Commons Attribution license, CC BY 4.0. This licencse permits unrestricted use, distribution and reproduction in any medium, provided that the original work is properly cited.
  • The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.
  • Because the advice and information in this journal are believed to be true and accurate at the time of publication, neither the authors, the editors, nor the publisher accept any legal responsibility for any errors or omissions presented in the publication. The publisher makes no guarantee, express or implied, with respect to the material contained herein.
  • The authors can enter into additional contracts for the non-exclusive distribution of the journal's published version by citing the initial publication in this journal (e.g. publishing in an institutional repository or in a book).

Most read articles by the same author(s)